Paper468900
Antitumor activity of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea (MeCCNU) on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
Bhide S and 3 others. J Cancer Res Clin Oncol, 1979. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Antitumor activity of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea (MeCCNU) on Yoshida sarcoma ascites cells implanted into the colon wall of rats. Papers, record 468900. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/468900
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Antitumor activity of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea (MeCCNU) on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carmustine | Major topic |
| Colonic Neoplasms | Major topic |
| Nitrosourea Compounds | Major topic |
| Sarcoma, Yoshida | Major topic |
| Semustine | Major topic |
| Animals | |
| Body Weight | |
| Cyclophosphamide | |
| Male | |
| Rats |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4563045 | 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review. | Adv Cancer Res | 1972 | https://conductscience.org/library/papers/4563045 | PubMed |
| 2 | 182365 | Nitrosourea combinations in lung cancer. | Cancer Treat Rep | 1976 | https://conductscience.org/library/papers/182365 | PubMed |
| 3 | 782695 | Clinical studies in malignant gliomas and their treatment with the nitrosoureas. | Cancer Treat Rep | 1976 | https://conductscience.org/library/papers/782695 | PubMed |
| 4 | 1116106 | A phase II study of methyl CCNU in the treatment of solid tumors and lymphomas: a Southwest Oncology Group study. | Cancer | 1975 | https://conductscience.org/library/papers/1116106 | PubMed |
| 5 | 954013 | Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer. | Cancer Treat Rep | 1976 | https://conductscience.org/library/papers/954013 | PubMed |
| 6 | 779949 | Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study. | Cancer | 1976 | https://conductscience.org/library/papers/779949 | PubMed |
| 7 | 782694 | Nitrosoureas: a review of experimental antitumor activity. | Cancer Treat Rep | 1976 | https://conductscience.org/library/papers/782694 | PubMed |
| 8 | 782696 | Nitrosoureas in the management of disseminated malignant melanoma. | Cancer Treat Rep | 1976 | https://conductscience.org/library/papers/782696 | PubMed |
| 9 | 782699 | Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer. | Cancer Treat Rep | 1976 | https://conductscience.org/library/papers/782699 | PubMed |
| 10 | 4748872 | Therapy of advanced gastrointestinal cancer with the nitrosoureas. | Cancer Chemother Rep 3 | 1973 | https://conductscience.org/library/papers/4748872 | PubMed |
| 11 | 151400 | Chemotherapy studies in autochthonous rat tumors intestinal cancer. | Z Krebsforsch Klin Onkol Cancer Res Clin Oncol | 1978 | https://conductscience.org/library/papers/151400 | PubMed |
| 12 | 582732 | Studies on the effect of cyclophosphamide on Yoshida sarcoma ascites cells implanted into the colon wall of rats. | Arzneimittelforschung | 1979 | https://conductscience.org/library/papers/582732 | PubMed |
| 13 | 782697 | Nitrosoureas as single agents in the treatment of pulmonary cancer. | Cancer Treat Rep | 1976 | https://conductscience.org/library/papers/782697 | PubMed |
| 14 | 174794 | Transplantable colon tumors as chemotherapy screening models. | Cancer | 1975 | https://conductscience.org/library/papers/174794 | PubMed |
| 15 | 954012 | Therapy for gastrointestinal cancer with the nitrosoureas alone and in drug combination. | Cancer Treat Rep | 1976 | https://conductscience.org/library/papers/954012 | PubMed |
| 16 | 1100221 | Clinical comparison of the nitrosoureas. | Cancer | 1975 | https://conductscience.org/library/papers/1100221 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7309781 | Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats. | J Cancer Res Clin Oncol | 1981 | https://conductscience.org/library/papers/7309781 | PubMed |
| 6503501 | [Effect of local moderate hyperthermia in combination with chemotherapy by N-nitroso-1,3-bis-(2-chloroethyl)urea (BCNU) on the descending colon of the rat with transplanted Yoshida sarcoma. 2. Monochemotherapy in combination with subsequent hyperthermia at various time intervals]. | Langenbecks Arch Chir | 1984 | https://conductscience.org/library/papers/6503501 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/468900
GET https://conductscience.org/api/papers/v1/468900/authors